Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive versus standard-dose Compound Danshen Dripping Pills for refractory angina unsuitable for revascularization
ChiCTR-IIR-17013662Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Compound Danshen in angina pectoris (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Change in total exercise time from baseline. Started Oct 2018; status: recruiting.
02
Drugs
Compound Danshen
03
Conditions
angina pectoris
Beyond the preview
Go deeper on ChiCTR-IIR-17013662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17013662.